ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Approves Afinitor Tablets For Advanced Breast Cancer

August 31, 2012

Research Policy: NIH Trials Don’t Enroll Enough Women to Allow Analysis, GAO Says in Report

May 12, 2000

DePinho’s Handling Of MD Anderson Tenure Dispute Triggers Formal Investigation by AAUP

July 18, 2014

In Brief: Sandor Eckhardt Is New UICC President; New Delhi Is Site Of 1994 UICC Meeting

August 31, 1990

NCAB, Hammer Agree On how 41 Billion To Be Handled: No String Attached

October 14, 1988

Resolutions Urge Doubling Of NIH Budget From ’98 Level.

March 9, 2001